ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,775,976 6.440% | 949,162 (+51.96%) | Filing |
| 2024-02-07 08:01 am Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,826,814 5.990% | 499,814 (+37.66%) | Filing |
| 2023-10-12 4:30 pm Purchase | 2023-10-02 | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,327,000 8.690% | 1,327,000 (New Position) | Filing |